Case Title: AG Oncon, LLC, et al. v. Ligand Pharmaceuticals, Inc.

Citation: 

Docket Number: 

State: delaware

Court: Delaware Supreme Court

Date: 2020-01-10T00:00:00Z

Document:
IN THE SUPREME COURT OF THE STATE OF DELAWARE AG ONCON, LLC, AG OFCON, § LTD, AND OPTI OPPORTUNITY § MASTER FUND, § § No. 300, 2019 Plaintiffs Below, § Appellants, § Court Below—Court of Chancery § of the State of Delaware v. § § LIGAND PHARMACEUTICALS, § C.A. No. 2018-0556 INC., § § Defendant Below, § Appellee. § Submitted: January 8, 2020 Decided: January 10, 2020 Before SEITZ, Chief Justice; VALIHURA, VAUGHN, TRAYNOR, and MONTGOMERY-REEVES, Justices, constituting the Court en Banc. ORDER This 10th day of January, 2020, after careful consideration of the parties’ briefs and the record on appeal, and after oral argument, we find it evident that the final judgment of the Court of Chancery should be affirmed on the basis of and for the reasons stated in its May 24, 2019 memorandum opinion. NOW, THEREFORE, IT IS ORDERED that the judgment of the Court of Chancery is AFFIRMED. BY THE COURT: /s/ Collins J. Seitz, Jr. Chief Justice